Hematide To Pose Threat to AMGN's Base Business From Late 2011 - Benzinga PDF Print
BenzingaAccording to Citi, Affymax may price Hematide at roughly 25% discount in order to capture share in the dialysis and pre-dialysis markets.

... read more

 
Share |
Copyright © 2026 Global Dialysis. All Rights Reserved.